Hemab Therapeutics Holdings Inc（COAG）价格预测

$44.020

-1.646 (-3.74%)收盘时

价格预测

1-Day Price Prediction

+0.92%

1-Week Prediction

+3.58%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

COAG 相似图表分析预测

Alphio's COAG stock price prediction model matches the current Hemab Therapeutics Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $44.42 (+0.92%). The 1-week path is $45.60 (+3.58%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Hemab Therapeutics Holdings Inc 股票吗？

Currently, Hemab Therapeutics (COAG) is trading at $44.84, significantly below the average analyst price target of $60, indicating potential upside. However, the stock has a low RSI of 29.128, suggesting it is oversold, but it also reported a wider Q2 loss of $24.2 million, which raises concerns about its financial health. Therefore, while there is potential for recovery, the current financial losses and market volatility suggest a cautious approach.